CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
U.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement Post author:GHIAA Admin Post published:September 1, 2023 Post category: Continue ReadingU.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement
PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 31, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 31, 2023 Post category: Continue ReadingNIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 29, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
PHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 28, 2023 Post category: Continue ReadingPHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
PHS – Biosyn, HIV Prophylactic Exclusive License Agreement Post author:GHIAA Admin Post published:August 24, 2023 Post category: Continue ReadingPHS – Biosyn, HIV Prophylactic Exclusive License Agreement
NIH – Fluidigm, COVID-19 Diagnostic Development Agreement Post author:GHIAA Admin Post published:August 23, 2023 Post category: Continue ReadingNIH – Fluidigm, COVID-19 Diagnostic Development Agreement
NIH – Non-Profit, Model License Agreement Terms Post author:GHIAA Admin Post published:August 11, 2023 Post category: Continue ReadingNIH – Non-Profit, Model License Agreement Terms